AJMC October 21, 2024
Pearl Steinzor

Key Takeaways

  • Specialty pharmaceutical pipeline discussions focused on novel treatments and the complexities of drug coverage policies.
  • Vertical integration of PBMs and insurers creates inconsistencies in specialty drug access, complicating patient navigation.
  • Biosimilar adoption faces challenges like reimbursement structures and requires innovative strategies to enhance uptake and reduce costs.
  • The 2024 presidential election could significantly impact health policy, with potential shifts in the ACA, drug pricing, and telehealth regulations.

The AMCP Nexus 2024 annual meeting covered a variety of hot health care topics impacting managed care pharmacy in the present and future.

The AMCP Nexus 2024 annual meeting took place between October 14 and October 17, 2024, in Las Vegas, Nevada. The conference featured over 30 education sessions...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Biotechnology, Conferences / Podcast, Pharma, Pharma / Biotech, Trends
Related Articles:
More than half of US adults could benefit from GLP-1 medications, researchers find
RNA editing is the next frontier in gene therapy—here's what you need to know
Rand roadblock: Biotech bill’s uncertain future
How Digital Chemistry Will Improve Cross-Functional Collaboration In The Biopharma Industry
GLP-1 drug coverage for obesity making inroads with large employers: Mercer

Share This Article